Codexis (CDXS) Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme
Go back to Codexis (CDXS) Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary EnzymeCODEXIS (NASDAQ: CDXS) | Delayed: 2.83 +0.03 (1.07%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.80 | 52 Week High | $5.25 | |||
Open | $2.77 | 52 Week Low | $2.93 | |||
Day High | $2.87 | P/E | N/A | |||
Day Low | $2.71 | EPS | $-1.25 | |||
Volume | 465,339 |